Insider · CIK 0002006197
Christian Bruhlmann
Files at ONCO (Onconetix, Inc.). First filing -, latest -.
In brief
Christian Bruhlmann files SEC Form 4 as officer at ONCO (Onconetix, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christian Bruhlmann has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | ONCO Onconetix, Inc. | AGrant or award Common Stock | +177,462 | $0.00 | $0 | 611,372 | Jan 22, 2025 |
Questions about Christian Bruhlmann
Answered from the filings on this page, as of the latest one.
Is Christian Bruhlmann buying or selling?
Christian Bruhlmann has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christian Bruhlmann's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christian Bruhlmann has 0.
Where does Christian Bruhlmann file Form 4?
Christian Bruhlmann has filed Form 4 at ONCO (Onconetix, Inc.) as Chief Strategy Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.